- Home
- WLKP vs MPLT Comparison
WLKP vs MPLT Comparison
Compare WLKP & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WLKP | MPLT |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 756.4M | 772.7M |
| IPO Year | 2014 | 2025 |
Fundamental Metrics
Financial Performance| Metric | WLKP | MPLT |
|---|---|---|
| Price | $21.85 | $17.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $31.00 |
| AVG Volume (30 Days) | 46.7K | ★ 191.7K |
| Earning Date | 02-23-2026 | 02-28-2026 |
| Dividend Yield | ★ 8.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $1,133,706,000.00 | N/A |
| Revenue This Year | $3.88 | N/A |
| Revenue Next Year | $12.71 | N/A |
| P/E Ratio | $15.72 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.75 | $12.24 |
| 52 Week High | $25.04 | $21.55 |
Technical Indicators
Market Signals| Indicator | WLKP | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 71.84 | 46.41 |
| Support Level | $21.03 | $17.06 |
| Resistance Level | $21.69 | $19.34 |
| Average True Range (ATR) | 0.41 | 1.54 |
| MACD | 0.06 | -0.05 |
| Stochastic Oscillator | 75.54 | 31.57 |
Price Performance
Historical ComparisonAbout WLKP Westlake Chemical Partners LP
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About MPLT MapLight Therapeutics Inc.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.